Knoxville, TN, United States of America

James S Foster

USPTO Granted Patents = 8 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 34(Granted Patents)


Location History:

  • Vancouver, WA (US) (1996)
  • Knoxville, TN (US) (2018 - 2024)

Company Filing History:


Years Active: 1996-2025

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovations of James S. Foster

Introduction

James S. Foster is a prominent inventor based in Knoxville, TN (US). He has made significant contributions to the field of immunology, particularly in the development of modified immunoglobulins for targeting amyloid deposits. With a total of 8 patents to his name, Foster's work has the potential to impact the treatment of amyloid-based diseases.

Latest Patents

Foster's latest patents include innovative modified immunoglobulins that comprise an amyloid reactive peptide joined to an antibody. These humanized antibodies are designed to bind to human amyloid fibrils and include antibody-peptide fusion proteins. Additionally, he has developed methods for treating amyloid-based diseases by administering these modified immunoglobulins, humanized antibodies, or antibody-peptide fusion proteins.

Career Highlights

Throughout his career, James S. Foster has worked with notable organizations such as the University of Tennessee Research Foundation and Attralus, Inc. His research has focused on advancing the understanding and treatment of amyloid-related conditions, showcasing his dedication to improving healthcare outcomes.

Collaborations

Foster has collaborated with esteemed colleagues, including Jonathan Wall and Spencer Guthrie. These partnerships have further enriched his research and contributed to the development of innovative solutions in the field of immunology.

Conclusion

James S. Foster's contributions to the field of immunology through his patents and collaborations highlight his role as a leading inventor. His work continues to pave the way for advancements in the treatment of amyloid-based diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…